Compare SNY & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNY | PFE |
|---|---|---|
| Founded | 1994 | 1849 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4B | 141.6B |
| IPO Year | N/A | N/A |
| Metric | SNY | PFE |
|---|---|---|
| Price | $47.39 | $25.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 11 |
| Target Price | ★ $61.50 | $27.18 |
| AVG Volume (30 Days) | 2.8M | ★ 43.1M |
| Earning Date | 01-29-2026 | 02-03-2026 |
| Dividend Yield | 3.39% | ★ 6.71% |
| EPS Growth | 105.93 | ★ 131.89 |
| EPS | ★ 8.67 | 1.73 |
| Revenue | $53,890,648,839.00 | ★ $62,785,000,000.00 |
| Revenue This Year | $1.73 | N/A |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | ★ $5.44 | $14.86 |
| Revenue Growth | N/A | ★ 3.89 |
| 52 Week Low | $44.62 | $20.92 |
| 52 Week High | $60.12 | $27.69 |
| Indicator | SNY | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 47.02 | 55.92 |
| Support Level | $46.10 | $25.51 |
| Resistance Level | $48.17 | $26.31 |
| Average True Range (ATR) | 0.80 | 0.50 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 51.10 | 65.55 |
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.